Brain scan study for tumor diagnosis and treatment response
Part of Brain & nervous system, Cancer clinical trials.
This study uses a special PET scan to look at brain tumors (both new and returning) to help doctors understand them better and see how well treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with or are suspected of having a brain tumor (either primary or spread from another cancer)
- You are able to have a PET scan (including the contrast dye)
- You have signed a consent form agreeing to take part
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special imaging agent called fluoroethyltyrosine (FET) to see if it can better detect brain tumors on PET scans. It may help doctors decide if a tumor has come back after treatment or better guide initial biopsy or surgery.
This study uses a special type of MRI scan combined with PET imaging to look at brain tumors after treatment. It aims to figure out whether new spots seen on MRI are leftover tumor or treatment effects, which could help guide your next care steps.
This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.
This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.
This study uses a special type of brain scan (PET imaging) to better understand how cancer that has spread to the brain responds to radiation treatment. The scan may help doctors see which patients are responding well to treatment.
This study uses a special PET scan to help doctors tell the difference between side effects of radiation (pseudoprogression) and actual tumor growth in people with glioblastoma. It aims to avoid unnecessary treatments and guide the next steps in your care.
Hear when a new Brain Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.